Apceth Biopharma

Apceth Biopharma, founded in 2007, is a pioneer in cell and gene therapy and has since evolved into Europe's leading contract development and manufacturing organization (CDMO) for advanced therapy medicinal products (ATMPs). The company operates state-of-the-art facilities located in Munich, Germany, fully compliant with all current EU ATMP (Advanced Therapy Medicinal Products) regulations, BSL2 (Biosafety Level 2) standards, and ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use) guidelines.